News

Find out about the latest developments in our dynamic translational research

T-cell landscape mapping identifies new targets for pancreatic cancer immunotherapy

Through analysis of T-cell populations, Oxford pancreatic researchers identify novel therapeutic opportunities in pancreatic cancer patients
An animation showing a dial with green, amber and red risk levels for myeloma

New clinical prediction tools for myeloma

Dr Constantinos Koshiaris has developed clinical prediction models for use in primary care with the aim of accelerating myeloma diagnoses.

Oxford at the American Association for Cancer Research Annual Meeting

Oxford researchers are out in force at next week’s AACR Annual Meeting, check out what they’ll be talking about

Early Detection Award for research into the clinical application of single cell genomics

Dr Onima Chowdhury will investigate the clinical application of single cell sequencing for early diagnosis and response prediction in myelodysplastic syndromes.
Doctor looking at skin

Higher testosterone levels in men linked to greater melanoma risk

New research from Dr Eleanor Watts at the Nuffield Department of Population Health has found this association for the first time

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.

Novel imaging device enters first round of development funding programme

Anna Vella is designing CAPULET: a device to increase the accuracy in delivering particle beam radiotherapy in cancer treatment

Oxford spin out influencing patient care world wide

Oxford cancer research spin our Optellum has received FDA clearance for the world’s first AI-powered clinical decision support for early lung cancer diagnosis

Funding to improve childhood, teenage and young adult cancer detection

Dr Defne Saatci and Professor Julia Hippisley-Cox will develop risk prediction tools using the QResearch database to support the earlier detection of childhood, teenage and young adult cancer

New partnership enables access to state-of-the-art radiotherapy machine

University of Oxford, OUH and GenesisCare have partnered to provide access to a new ViewRay MRIdian machine. It is the first of its kind in the UK and will help to improve challenging cancer treatment through faster, tailored radiotherapy.

DeLIVER clinical research study underway as recruitment opens

The DELPHI project, one of three clinical studies within the DeLIVER programme for early detection of liver cancer, has started recruiting patients.

Prof Andi Roy receives new award for immune-cell research

Co-funded by Cancer Research UK and Children with Cancer UK, Andi is one of 5 to receive £1 million each to investigate children’s and young people’s cancers.